Incyte Pharmaceuticals, Inc.

Incyte Genomics, Inc.

Incyte Corporation

Other

Inctye Pharmaceuticals, Inc.

Incyte Pharmacueticals, Inc.

Incyte Pharamceuticals, Inc.

Jennifer L Hillman

Neil C Corley

Purvi Shah

Surya K Goli

Preeti G Lal

Olga Bandman

Karl J Guegler

Janice K Au-Young

Henry Yue

Phillip R Hawkins

Y Tom Tang

Chandra Patterson

Mariah R Baughn

Lynn E Murry

Ingrid E Akerblom

Matthew R Kaser

Gina A Gorgone

Yalda Azimzai

David Gray Streeter

Timothy J Maslyn

Dyung Aina M Lu

Chandra S Arvizu

Harold H Hibbert

Rachel J Cheng

Yuanhua T Tang

Jeffrey J Seilhamer

Roger T Coleman

Tod M Klingler

Benjamin Graeme Cocks

Roopa M Reddy

Gary B Zweiger

Gina A Gorgone Simone

Preete Mathur

Christina M Altus

Hong Zhang

Frank D Russo

Susan G Stuart

April J A Hafalia

Ameena R Gandhi

Monique G Yao

Angelo M Delegeane

Danniel B Nguyen

Junming Yang

Richard D Goold

Catherine M Tribouley

Narinder K Walia

Joanne R Petithory

Roopa Reddy

Farrah A Khan

Jennifer L Policky

Debopriya Das

Dyung Aina Lu

Sherry A Capitant

Sajeev Batra

Steve E Lincoln

Wendy B Levine

Samuel T LaBrie

Pretti Lal

Y Tom Yang

Yalda Azimazai

The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Compositions comprising signal peptide-containing proteins

Polynucleotides encoding signal peptide-containing molecules

The invention provides human protease molecules (HUPM) and polynucleotides which identify and encode HUPM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUPM.

Methods for detecting expression of human protease molecules

The invention provides human molecules associated with cell proliferation (MACP) and polynucleotides which identify and encode MACP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of MACP.

Polynucleotides encoding molecules associated with cell proliferation

The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME.

Human phospholipases

The invention provides human electron transport proteins (NHETP) and polynucleotides which identify and encode NHETP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of NHETP.

Electron transport proteins

Human protease molecules

The present invention provides a human guanosine monophosphate reductase (HGMPR) and polynucleotides which identify and encode HGMPR. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HGMPR and a method for producing HGMPR. The invention also provides for agonists, antibodies, or antagonists specifically binding HGMPR, and their use, in the prevention and treatment of diseases associated with expression of HGMPR. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HGMPR for the treatment of diseases associated with the expression of HGMPR. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HGMPR.

Guanosine monophosphate reductase

The invention provides human protease associated proteins (HPRAP) and polynucleotides which identify and encode HPRAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HPRAP.

Human protease associated proteins

The invention provides human hydrolytic enzymes (HYENZ) and polynucleotides which identify and encode HYENZ. The invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HYENZ.

Human hydrolytic enzymes

The present invention provides a human lysophospholipase (NHLP) and polynucleotides which identify and encode NHLP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. In addition, the invention provides methods for producing NHLP and for treating or preventing disorders associated with expression of NHLP.

Human lysophospholipase

The invention provides human oxidoreductase molecules (OXRE) and polynucleotides which identify and encode OXRE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of OXRE.

DNA encoding oxidoreductase and polypeptide encoded thereby

The invention provides a human new glutathione S-transferase (GSTS) and polynucleotides which identify and encode GSTS. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of GS.

Glutathione S-transferase

The invention provides human ubiquitin-conjugating enzyme homologs (UCEH) and polynucleotides which identify and encode UCEH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of UCEH.

Human ubiquitin-conjugating enzyme homologs

Growing community of inventors

Mountain View, CA, United States of America

Jennifer L Hillman